ALKERMES | ALKS - Kapitalisasi Pasar

Harga Saham
33.60
Perubahan Harian
-0.11 -0.33%
Bulanan
-4.98%
Tahunan
9.88%
Q2 Perkiraan
32.32




Kapitalisasi Pasar Perubahan Tanggal
AbbVie USD 360.74B 23.94B 2026-04
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 187.49B 11.24B 2026-04
Biogen USD 28.34B 1.44B 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 122.54B 1.29B 2026-04
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 882.91B 13.89B 2026-04
Gilead Sciences USD 166.62B 14.34B 2026-04
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 10.9B 1.55B 2026-04
J&J USD 561.65B 17.5B 2026-04
Malin Corporation EUR 142.92M 19.65M 2026-02
Merck USD 279.96B 18.7B 2026-04
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Otsuka Holdings JPY 6T 26.39B 2026-04
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 75.34B 6.35B 2026-04
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12